Tower Research Capital (TRC)’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-185
Closed -$1.1K 5254
2025
Q1
$1.1K Buy
185
+115
+164% +$683 ﹤0.01% 4771
2024
Q4
$932 Sell
70
-682
-91% -$9.08K ﹤0.01% 5131
2024
Q3
$6.11K Sell
752
-3,715
-83% -$30.2K ﹤0.01% 4181
2024
Q2
$38K Buy
4,467
+4,231
+1,793% +$36K ﹤0.01% 3305
2024
Q1
$4.1K Sell
236
-576
-71% -$10K ﹤0.01% 4739
2023
Q4
$10.4K Buy
812
+486
+149% +$6.23K ﹤0.01% 4252
2023
Q3
$12.1K Sell
326
-741
-69% -$27.4K ﹤0.01% 3930
2023
Q2
$42.9K Buy
1,067
+705
+195% +$28.4K ﹤0.01% 2691
2023
Q1
$26K Buy
362
+279
+336% +$20K ﹤0.01% 3140
2022
Q4
$7K Sell
83
-635
-88% -$53.6K ﹤0.01% 4525
2022
Q3
$68K Buy
718
+199
+38% +$18.8K ﹤0.01% 2883
2022
Q2
$101K Sell
519
-282
-35% -$54.9K ﹤0.01% 2283
2022
Q1
$186K Buy
801
+516
+181% +$120K ﹤0.01% 1792
2021
Q4
$112K Sell
285
-574
-67% -$226K ﹤0.01% 2157
2021
Q3
$385K Buy
859
+656
+323% +$294K 0.01% 1177
2021
Q2
$79K Sell
203
-112
-36% -$43.6K ﹤0.01% 2611
2021
Q1
$113K Sell
315
-45
-13% -$16.1K ﹤0.01% 2498
2020
Q4
$176K Buy
360
+239
+198% +$117K 0.01% 1818
2020
Q3
$39K Sell
121
-575
-83% -$185K ﹤0.01% 3636
2020
Q2
$253K Buy
+696
New +$253K 0.01% 1595
2020
Q1
Sell
-175
Closed -$72K 3025
2019
Q4
$72K Buy
175
+61
+54% +$25.1K 0.01% 1124
2019
Q3
$40K Buy
+114
New +$40K ﹤0.01% 1953
2019
Q2
Sell
-3
Closed -$3K 3652
2019
Q1
$3K Hold
3
﹤0.01% 3257
2018
Q4
$3K Sell
3
-96
-97% -$96K ﹤0.01% 3145
2018
Q3
$103K Buy
+99
New +$103K 0.01% 1324
2018
Q2
Sell
-219
Closed -$213K 3621
2018
Q1
$213K Buy
+219
New +$213K 0.02% 847
2017
Q4
Sell
-50
Closed -$21K 3505
2017
Q3
$21K Buy
50
+46
+1,150% +$19.3K ﹤0.01% 2692
2017
Q2
$1K Buy
+4
New +$1K ﹤0.01% 2457
2017
Q1
Sell
-22
Closed -$8K 3038
2016
Q4
$8K Buy
+22
New +$8K ﹤0.01% 2762
2016
Q1
Sell
-4
Closed -$3K 4089
2015
Q4
$3K Sell
4
-116
-97% -$87K ﹤0.01% 3385
2015
Q3
$94K Buy
120
+112
+1,400% +$87.7K 0.01% 604
2015
Q2
$11K Buy
8
+1
+14% +$1.38K ﹤0.01% 2601
2015
Q1
$8K Sell
7
-37
-84% -$42.3K ﹤0.01% 2937
2014
Q4
$29K Buy
+44
New +$29K ﹤0.01% 1348